VanHimbergen Robert M 4

What Happened

• Robert M. VanHimbergen, EVP and Chief Financial Officer of Elanco Animal Health (ELAN), was granted 7.938 deferred stock units on July 10, 2026. The units are recorded at $24.82 each for an aggregate value of $197. This transaction is coded as an award/grant (A) and is a derivative award rather than an open‑market buy or sell.

Key Details

• Transaction date: 2026-07-10; filing date: 2026-07-14 (filed within standard 2 business days).
• Grant: 7.938 deferred stock units @ $24.82 per unit; aggregate value reported $197.
• Transaction type: Award / grant of deferred stock units (derivative instrument).
• Shares owned after the transaction: Not reported in the provided filing.
• Footnotes: F1 — each deferred stock unit represents the right to receive one share or the cash equivalent; F2 — units settle in cash or shares upon termination of employment or in a specified future year under the Executive Deferral and Stock Match Plan.
• No 10b5-1 plan, tax-withholding sale, or immediate sale indicated.

Context

• Deferred stock units are a form of compensation deferral: they represent a future right to receive company shares or cash and do not necessarily mean immediate share ownership or selling activity. Such grants are typically routine compensation/retention awards for executives and should be interpreted as compensation-related, not as an immediate bullish or bearish trading signal.